200 Participants NeededMy employer runs this trial

Anti-Smoking Messages for Smoking

Recruiting at 1 trial location
LP
Overseen ByLyudmila Popova, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Georgia State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

\<p\>The goal of this clinical trial is to learn how exposure to anti-smoking social media messages affects quitting-related behaviors. Eligible participants will be adults aged 21 or older who have used menthol cigarettes on at least 4 days during the past 30 days.\</p\> \<br\> \<p\>The main question this study aims to answer is: Does exposure to anti-smoking messages (in the context of a discrete choice experiment \[DCE\] with eye-tracking study) increase quitting-related behaviors over the following 2 weeks?\</p\> \<br\> \<p\>Participants will be randomly assigned to view the messages either immediately or after a 2-week waiting period, allowing researchers to compare quitting-related behaviors between the two groups. The primary outcome is whether participants report making a quit attempt in the 2 weeks following randomization.\</p\> \<br\> \<p\>Participants will:\</p\> \<ul\> \<li\>Complete eligibility screening and baseline questions about demographics and tobacco use.\</li\> \<li\>Be randomly assigned to view the messages immediately or after a 2-week waiting period.\</li\> \<li\>Attend a 1-hour in-person study visit at Georgia State University or the University of California, Santa Barbara.\</li\> \<li\>View 64 anti-smoking social media messages presented in 16 choice sets while their eye movements and pupil dilation are measured using a screen-based eye-tracking device.\</li\> \<li\>Select which messages most attract their attention, which they would be most likely to share, and which would most motivate them to quit smoking.\</li\> \<li\>Complete questions about quitting-related behaviors either during the study visit (waitlist control condition) or through an online questionnaire 2 weeks later (immediate condition).\</li\> \</ul\>

Are You a Good Fit for This Trial?

This trial is for adults aged 21 or older who smoke menthol cigarettes at least once a week and can attend an in-person visit. Participants must speak, read, and write English. People with certain eye conditions or special glasses that interfere with eye-tracking can't join.

Inclusion Criteria

I am willing to take part in an in-person study.
Can speak, read, and write in English
I am 21 years old or older.
See 1 more

Exclusion Criteria

Use of multifocal or near-infrared-blocking/heavily tinted corrective lenses such as bifocal, trifocal, or progressive/varifocal lenses, or coatings that impair eye-tracking (single-vision glasses and contact lenses are eligible)
I have an eye condition that affects my ability to focus or see clearly in the center of my vision.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Waitlist Control

Participants wait 2 weeks before attending an in-person visit to answer questions about quitting-related behaviors and complete the DCE/eye-tracking study

2 weeks
1 visit (in-person)

Immediate Condition

Participants complete the in-person DCE/eye-tracking study visit immediately after randomization and then complete an online questionnaire assessing quitting-related behaviors 2 weeks later

2 weeks
1 visit (in-person), 1 visit (virtual)

Follow-up

Participants are monitored for quitting-related behaviors and intentions to quit smoking

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Message Exposure via Discrete Choice Experiment

Trial Overview

The study tests whether seeing anti-smoking social media messages affects quit attempts among menthol cigarette smokers. Participants are randomly assigned to view these messages either right away or after two weeks while their eye movements are tracked.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: DCE exposureExperimental Treatment1 Intervention
Group II: Waitlist ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Georgia State University

Lead Sponsor

Trials
71
Recruited
33,600+

University of California, Santa Barbara

Collaborator

Trials
33
Recruited
3,100+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+